Cigna Group Financials
Cigna Group (CI) reported $274.9B in revenue for fiscal year 2025, up 11.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue scale keeps expanding, but thin operating margins make this a throughput business where bigger sales do not automatically mean bigger profit.
From FY2023 to FY2025, revenue increased by$79.6B , yet operating income rose only$664M and operating cash flow fell from$11.8B to$9.6B . That combination points to lower incremental profitability and weaker cash conversion on new volume, so recent growth looks more like added throughput than added earnings power.
The balance sheet is not cash-heavy: cash stayed near
Per-share results got help from a shrinking share base: shares outstanding fell from 292.4M in FY2023 to 263.5M in FY2025 while operating income in FY2025 was still only
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cigna Group's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Cigna Group has an operating margin of 3.4%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 60/100, indicating healthy but not exceptional operating efficiency. This is down from 3.8% the prior year.
Cigna Group's revenue grew 11.2% year-over-year to $274.9B, a solid pace of expansion. This earns a growth score of 80/100.
Cigna Group has a moderate D/E ratio of 0.74. This balance of debt and equity financing earns a leverage score of 31/100.
Cigna Group's current ratio of 0.85 is below the typical benchmark, resulting in a score of 13/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Not available for Cigna Group, and counted as zero in the overall score.
Cigna Group earns a strong 14.3% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 74/100. This is up from 8.4% the prior year.
Cigna Group scores 2.67, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cigna Group passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Cigna Group generates $1.61 in operating cash flow ($9.6B OCF vs $6.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Cigna Group earns $6.57 in operating income for every $1 of interest expense ($9.2B vs $1.4B). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Cigna Group generated $274.9B in revenue in fiscal year 2025. This represents an increase of 11.2% from the prior year.
Cigna Group's EBITDA was $12.0B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.8% from the prior year.
Cigna Group reported $6.0B in net income in fiscal year 2025. This represents an increase of 73.5% from the prior year.
Cigna Group earned $22.18 per diluted share (EPS) in fiscal year 2025. This represents an increase of 83.0% from the prior year.
Cash & Balance Sheet
Cigna Group held $7.7B in cash against $30.9B in long-term debt as of fiscal year 2025.
Cigna Group paid $6.04 per share in dividends in fiscal year 2025. This represents an increase of 7.9% from the prior year.
Not reported for fiscal year 2025.
Margins & Returns
Cigna Group's operating margin was 3.4% in fiscal year 2025, reflecting core business profitability. This is down 0.5 percentage points from the prior year.
Cigna Group's net profit margin was 2.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.8 percentage points from the prior year.
Cigna Group's ROE was 14.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 5.9 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Cigna Group spent $3.6B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 48.5% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
CI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $282.4B | $274.9B+11.2% | $247.1B+26.6% | $195.3B+8.2% | $180.5B+3.7% | $174.1B+8.5% | $160.4B+4.5% | $153.6B+215.7% | $48.6B+16.4% | $41.8B+4.9% | $39.8B |
| Cost of Revenue | $224.1B | $215.0B+17.8% | $182.5B+36.4% | $133.8B+7.2% | $124.8B+6.2% | $117.6B+13.6% | $103.5B+6.0% | $97.7B+1937.7% | $4.8B+95.2% | $2.5B-0.5% | $2.5B |
| SG&A Expenses | $14.2B | $14.6B-1.5% | $14.8B+0.1% | $14.8B+12.5% | $13.2B+1.2% | $13.0B-7.5% | $14.1B+0.1% | $14.1B+17.8% | $11.9B+19.0% | $10.0B+2.5% | $9.8B |
| Operating Income | $10.0B | $9.2B-2.3% | $9.4B+10.3% | $8.5B+1.0% | $8.4B+6.4% | $7.9B-2.6% | $8.2B+0.9% | $8.1B+94.2% | $4.2B+5.5% | $3.9B+27.7% | $3.1B |
| Interest Expense | $1.4B | $1.4B-6.7% | $1.5B+7.1% | $1.4B+7.7% | $1.3B0.0% | $1.3B-7.1% | $1.4B-12.5% | $1.6B+215.6% | $507.0M+108.6% | $243.0M-3.2% | $251.0M |
| Income Tax | $1.7B | $1.5B+0.1% | $1.5B+957.4% | $141.0M-91.3% | $1.6B+17.9% | $1.4B-42.4% | $2.4B+64.1% | $1.4B+55.1% | $935.0M-32.0% | $1.4B+21.0% | $1.1B |
| Net Income | $6.4B | $6.0B+73.5% | $3.4B-33.5% | $5.2B-23.9% | $6.8B+25.1% | $5.4B-36.2% | $8.5B+65.8% | $5.1B+93.5% | $2.6B+18.5% | $2.2B+21.1% | $1.8B |
| EPS (Diluted) | — | $22.18+83.0% | $12.12-30.3% | $17.39-18.8% | $21.41+35.9% | $15.75-31.4% | $22.96+70.8% | $13.44 | $10.54+20.2% | $8.77+22.0% | $7.19 |
Not reported in any period shown, so not listed: Gross Profit, R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $157.9B+1.3% | $155.9B+2.0% | $152.8B+6.2% | $143.9B-7.1% | $154.9B-0.4% | $155.5B-0.2% | $155.8B+1.7% | $153.2B+148.1% | $61.8B | N/A |
| Current Assets | $47.8B-2.2% | $48.9B+30.8% | $37.4B+24.0% | $30.1B-16.6% | $36.1B+30.0% | $27.8B-6.9% | $29.8B+46.1% | $20.4B+119.4% | $9.3B | N/A |
| Cash & Equivalents | $7.7B+1.7% | $7.5B-3.5% | $7.8B+32.0% | $5.9B+16.6% | $5.1B-50.1% | $10.2B+120.4% | $4.6B+19.8% | $3.9B+29.7% | $3.0B-6.7% | $3.2B |
| Inventory | $7.3B+9.7% | $6.7B+18.5% | $5.6B+18.2% | $4.8B+28.3% | $3.7B+17.6% | $3.2B+18.9% | $2.7B-5.7% | $2.8B+1137.3% | $228.0M | N/A |
| Goodwill | $44.9B+1.2% | $44.4B+0.3% | $44.3B-3.4% | $45.8B0.0% | $45.8B+2.6% | $44.6B+0.1% | $44.6B+0.2% | $44.5B+622.0% | $6.2B+3.1% | $6.0B |
| Total Liabilities | $116.0B+1.2% | $114.6B+7.7% | $106.4B+7.3% | $99.1B-8.0% | $107.7B+2.5% | $105.1B-4.8% | $110.4B-1.6% | $112.2B+133.7% | $48.0B | N/A |
| Current Liabilities | $56.3B-2.8% | $58.0B+19.0% | $48.7B+18.2% | $41.2B-5.4% | $43.6B+21.0% | $36.0B-10.3% | $40.1B+25.8% | $31.9B+189.7% | $11.0B | N/A |
| Long-Term Debt | $30.9B+6.7% | $28.9B+2.8% | $28.2B+0.2% | $28.1B-9.7% | $31.1B+5.3% | $29.5B-7.4% | $31.9B-19.3% | $39.5B+660.2% | $5.2B | N/A |
| Total Equity | $41.7B+1.7% | $41.0B-11.2% | $46.2B+3.5% | $44.7B-5.2% | $47.1B-6.4% | $50.3B+11.0% | $45.3B+10.5% | $41.0B+199.2% | $13.7B+0.1% | $13.7B |
| Retained Earnings | $47.9B+10.0% | $43.5B+4.5% | $41.7B+9.8% | $37.9B+16.4% | $32.6B+14.1% | $28.6B+41.7% | $20.2B+33.6% | $15.1B-4.5% | $15.8B | N/A |
Not reported in any period shown, so not listed: Accounts Receivable.
CI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.3B | $9.6B-7.4% | $10.4B-12.3% | $11.8B+36.5% | $8.7B+20.4% | $7.2B-30.5% | $10.3B+9.1% | $9.5B+151.6% | $3.8B-7.7% | $4.1B+1.5% | $4.0B |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $1.1B+98.9% | $528.0M+12.1% | $471.0M+2.2% | $461.0M |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $8.4B+160.2% | $3.2B-10.3% | $3.6B+1.4% | $3.6B |
| Investing Cash Flow | -$5.9B | -$4.4B-109.7% | -$2.1B+59.4% | -$5.2B-267.0% | $3.1B+185.8% | -$3.6B-221.3% | $3.0B+505.4% | -$734.0M+97.2% | -$26.4B-1448.9% | -$1.7B+33.8% | -$2.6B |
| Financing Cash Flow | -$2.3B | -$6.4B+16.0% | -$7.6B-78.1% | -$4.3B+61.8% | -$11.2B-36.9% | -$8.2B+3.8% | -$8.5B-18.7% | -$7.2B-130.6% | $23.5B+987.0% | -$2.7B-1078.2% | -$225.0M |
| Dividends Paid | $1.6B | $1.6B+2.8% | $1.6B+8.1% | $1.4B+4.8% | $1.4B+3.2% | $1.3B+8840.0% | $15.0M0.0% | $15.0M | N/A | N/A | N/A |
| Share Buybacks | $1.3B | $3.6B-48.5% | $7.0B+208.0% | $2.3B-70.0% | $7.6B-1.7% | $7.7B+91.5% | $4.0B+103.4% | $2.0B+481.0% | $342.0M-87.4% | $2.7B+1860.4% | $139.0M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4%-0.5pp | 3.8%-0.6pp | 4.4%-0.3pp | 4.7%+0.1pp | 4.6%-0.5pp | 5.1%-0.2pp | 5.3%-3.3pp | 8.6%-0.9pp | 9.4%+1.7pp | 7.8% |
| Net Margin | 2.2%+0.8pp | 1.4%-1.3pp | 2.6%-1.1pp | 3.8%+0.7pp | 3.1%-2.2pp | 5.3%+2.0pp | 3.3%-2.1pp | 5.4%+0.1pp | 5.3%+0.7pp | 4.6% |
| Return on Equity | 14.3%+5.9pp | 8.4%-2.8pp | 11.2%-4.0pp | 15.2%+3.7pp | 11.5%-5.4pp | 16.9%+5.6pp | 11.3%+4.8pp | 6.5%-9.8pp | 16.3%+2.8pp | 13.5% |
| Return on Assets | 3.8%+1.6pp | 2.2%-1.2pp | 3.4%-1.3pp | 4.7%+1.2pp | 3.5%-2.0pp | 5.5%+2.2pp | 3.3%+1.6pp | 1.7%-1.9pp | 3.6% | N/A |
| Current Ratio | 0.850.0x | 0.84+0.1x | 0.770.0x | 0.73-0.1x | 0.83+0.1x | 0.770.0x | 0.74+0.1x | 0.64-0.2x | 0.85 | N/A |
| Debt-to-Equity | 0.740.0x | 0.71+0.1x | 0.610.0x | 0.630.0x | 0.66+0.1x | 0.59-0.1x | 0.70-0.3x | 0.96+0.6x | 0.38 | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | 5.5%-1.2pp | 6.7%-2.0pp | 8.6%-0.3pp | 8.9% |
Not reported in any period shown, so not listed: Gross Margin.
Note: The current ratio is below 1.0 (0.85), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Cigna Group Ranks
Frequently Asked Questions
What is Cigna Group's annual revenue?
Cigna Group (CI) reported $274.9B in total revenue for fiscal year 2025. This represents a 11.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cigna Group's revenue growing?
Cigna Group (CI) revenue grew by 11.2% year-over-year, from $247.1B to $274.9B in fiscal year 2025.
Is Cigna Group profitable?
Yes, Cigna Group (CI) reported a net income of $6.0B in fiscal year 2025, with a net profit margin of 2.2%.
What is Cigna Group's EBITDA?
Cigna Group (CI) had EBITDA of $12.0B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Cigna Group have?
As of fiscal year 2025, Cigna Group (CI) had $7.7B in cash and equivalents against $30.9B in long-term debt.
What is Cigna Group's operating margin?
Cigna Group (CI) had an operating margin of 3.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Cigna Group's net profit margin?
Cigna Group (CI) had a net profit margin of 2.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Cigna Group pay dividends?
Yes, Cigna Group (CI) paid $6.04 per share in dividends during fiscal year 2025.
What is Cigna Group's return on equity (ROE)?
Cigna Group (CI) has a return on equity of 14.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Cigna Group's operating cash flow?
Cigna Group (CI) generated $9.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cigna Group's total assets?
Cigna Group (CI) had $157.9B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Cigna Group's current ratio?
Cigna Group (CI) had a current ratio of 0.85 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Cigna Group's debt-to-equity ratio?
Cigna Group (CI) had a debt-to-equity ratio of 0.74 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cigna Group's return on assets (ROA)?
Cigna Group (CI) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cigna Group's Altman Z-Score?
Cigna Group (CI) has an Altman Z-Score of 2.67, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cigna Group's Piotroski F-Score?
Cigna Group (CI) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cigna Group's earnings high quality?
Cigna Group (CI) has an earnings quality ratio of 1.61x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Cigna Group cover its interest payments?
Cigna Group (CI) has an interest coverage ratio of 6.57x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Cigna Group?
Cigna Group (CI) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.